Assured Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-16,341
Closed -$1.92M 818
2019
Q1
$1.92M Sell
16,341
-34,148
-68% -$3.98M 0.02% 278
2018
Q4
$5.5M Sell
50,489
-8,646
-15% -$1M 0.16% 163
2018
Q3
$7.56M Buy
59,135
+9,858
+20% +$1.22M 0.14% 160
2018
Q2
$5.58M Buy
49,277
+40,208
+443% +$4.42M 0.1% 213
2018
Q1
$1.02M Sell
9,069
-17,393
-66% -$2.21M 0.02% 539
2017
Q4
$3.92M Sell
26,462
-50,856
-66% -$6.47M 0.08% 272
2017
Q3
$9.06M Buy
77,318
+58,402
+309% +$7.46M 0.19% 97
2017
Q2
$2.45M Buy
18,916
+8,872
+88% +$1.11M 0.05% 233
2017
Q1
$1.36M Buy
10,044
+9,033
+893% +$1.37M 0.03% 236
2016
Q4
$145K Sell
1,011
-8,340
-89% -$1.06M ﹤0.01% 531
2016
Q3
$1.1M Buy
9,351
+4,122
+79% +$495K 0.03% 284
2016
Q2
$554K Buy
5,229
+3,003
+135% +$335K 0.01% 395
2016
Q1
$248K Sell
2,226
-592
-21% -$74.9K 0.01% 455
2015
Q4
$441K Sell
2,818
-385
-12% -$56K 0.01% 331
2015
Q3
$420K Buy
3,203
+769
+32% +$123K 0.01% 389
2015
Q2
$423K Sell
2,434
-732
-23% -$132K 0.01% 391
2015
Q1
$546K Buy
+3,166
New +$483K 0.01% 228

Other funds holding UTHR

Assured Investment Management's UTHR Position: Q2 2019 in Review

Assured Investment Management sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 16,341 shares — an estimated $1.92M sold.

Assured Investment Management first reported a position in UTHR in Q1 2015 and held it in 17 quarters. The position peaked at $9.06M in Q3 2017. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • Assured Investment Management reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 16,341 United Therapeutics shares in Q2 2019, an estimated $1.92M.
  • Assured Investment Management first reported a position in United Therapeutics in Q1 2015 and held it in 17 quarters.
  • Assured Investment Management's United Therapeutics position peaked at $9.06M in Q3 2017.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.